zixuan cang
North Carolina State University
Raleigh, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
North Carolina State University
Raleigh, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Department of Chemistry, Faculty of Philosophy, Sciences and Languages of Ribeirão Preto, University of São Paulo
Ribeirão Preto, Brazil
Review Editor
Anti-Infective Agents
AstraZeneca (United Kingdom)
London, United Kingdom
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
University of Siena
Siena, Italy
Review Editor
Neurological Drugs
Moinhos de Vento Hospital
Porto Alegre, Brazil
Review Editor
Dermatologic Drugs
Karolinska Institutet (KI)
Solna, Sweden
Review Editor
Anti-Cancer Drugs
Federal University of Bahia (UFBA)
Salvador, Brazil
Review Editor
Anti-Infective Agents
Cogent Biosciences
Boulder, CO, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
University of Massachusetts Medical School
Worcester, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
Department of Cardiology, Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, China
Review Editor
Cardiovascular and Hematologic Drugs
Tufts Medical Center
Boston, United States
Review Editor
Cardiovascular and Hematologic Drugs
Shenyang Pharmaceutical University
Shenyang, China
Review Editor
Anti-Cancer Drugs
C4 Therapeutics
Watertown, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
Department of Pharmacy, College of Health Sciences, Debre Tabor University
Debre Tabor, Ethiopia
Review Editor
Technologies and Strategies to Enable Drug Discovery
University of North Carolina at Chapel Hill
Chapel Hill, United States
Review Editor
Anti-Cancer Drugs
University of Maryland
Baltimore, United States
Review Editor
Cardiovascular and Hematologic Drugs